Severity: Quantifying the Severity of Generalized Tonic-clonic Seizures (GTCS) With Connected Dev… (NCT05477121) | Clinical Trial Compass
CompletedNot Applicable
Severity: Quantifying the Severity of Generalized Tonic-clonic Seizures (GTCS) With Connected Devices
Switzerland400 participantsStarted 2019-06-12
Plain-language summary
By bringing together the fields of seizure detection and that of Sudden Unexpected Death in Epilepsy (SUDEP), the current project aims at delineating which set of biosensors and related biomarkers would optimally characterize the severity of GTCS and the associated risk of SUDEP.
Who can participate
Age range12 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or female aged 12 years or older, suffering from epilepsy
* Patient undergoing Video-EEG recording
* Patient at risk of presenting a GTCS during Video-EEG monitoring according to one of the following criteria (i) known to suffer from GTCS, or (ii) considered for Antiepileptic drugs (AED) tapering during Video-EEG (GTCS often occur during Video-EEG as a result of AED tapering for promoting the occurrence of seizures).
* Patient willing to participate in the study and signed informed consent, by patient or legal representative when required.
Exclusion Criteria:
* Patients aged less than 12 years old
* Patient not willing to participate in the study, and where informed consent from the patient or the legal representative, when required, cannot be obtained - Patient considered not at risk of presenting a GTCS during Video-EEG because they are not known to suffer GTCS and not candidate to AED tapering during Video-EEG.
What they're measuring
1
duration of PGES
Timeframe: Through study completion, an average of 4 years